BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24906351)

  • 1. Managing HIV and Hodgkin lymphoma in the twenty-first century.
    Aries J; Montoto S
    Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
    Montoto S; Shaw K; Okosun J; Gandhi S; Fields P; Wilson A; Shanyinde M; Cwynarski K; Marcus R; de Vos J; Young AM; Tenant-Flowers M; Orkin C; Johnson M; Chilton D; Gribben JG; Bower M
    J Clin Oncol; 2012 Nov; 30(33):4111-6. PubMed ID: 23045581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma in patients with HIV infection: a review.
    Martis N; Mounier N
    Curr Hematol Malig Rep; 2012 Sep; 7(3):228-34. PubMed ID: 22547166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.
    Besson C; Lancar R; Prevot S; Brice P; Meyohas MC; Marchou B; Gabarre J; Bonnet F; Goujard C; Lambotte O; Boué F; Mounier N; Partisani M; Raffi F; Costello R; Hendel-Chavez H; Algarte-Genin M; Trabelsi S; Marchand L; Raphael M; Taoufik Y; Costagliola D
    Clin Infect Dis; 2015 Nov; 61(9):1469-75. PubMed ID: 26223997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.
    Yotsumoto M; Hagiwara S; Ajisawa A; Tanuma J; Uehira T; Nagai H; Fujikawa Y; Maeda S; Kitano K; Arima N; Uno K; Iwai T; Hongo I; Ota Y; Fukutake K; Okada S
    Int J Hematol; 2012 Aug; 96(2):247-53. PubMed ID: 22752537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
    Xicoy B; Ribera JM; Miralles P; Berenguer J; Rubio R; Mahillo B; Valencia ME; Abella E; López-Guillermo A; Sureda A; Morgades M; Navarro JT; Esteban H; ;
    Haematologica; 2007 Feb; 92(2):191-8. PubMed ID: 17296568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
    Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
    Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
    Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M;
    Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma among patients infected with HIV in post-HAART era.
    Tanaka PY; Pessoa VP; Pracchia LF; Buccheri V; Chamone DA; Calore EE
    Clin Lymphoma Myeloma; 2007 Mar; 7(5):364-8. PubMed ID: 17562247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated Hodgkin lymphoma.
    Carbone A; Gloghini A; Serraino D; Spina M
    Curr Opin HIV AIDS; 2009 Jan; 4(1):3-10. PubMed ID: 19339934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
    Spina M; Gabarre J; Fasan M; Vaccher E; Tirelli U
    AIDS; 2000 Jul; 14(10):1457-8. PubMed ID: 10930165
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of HIV-associated Hodgkin lymphoma: how far we have come.
    Kaplan LD
    J Clin Oncol; 2012 Nov; 30(33):4056-8. PubMed ID: 23045587
    [No Abstract]   [Full Text] [Related]  

  • 16. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
    J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
    Gutiérrez-Saborido D; Gutiérrez-Valencia A; González Domenech CM; López Ruz MÁ; Raffo Márquez M; Omar M; Girón-González JA;
    Ann Hematol; 2019 Aug; 98(8):1953-1959. PubMed ID: 31025161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
    Ezzat HM; Cheung MC; Hicks LK; Boro J; Montaner JS; Lima VD; Harris M; Leitch HA
    Leuk Lymphoma; 2012 Dec; 53(12):2390-6. PubMed ID: 22642935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin lymphoma in HIV positive patients.
    Mounier N; Spina M; Spano JP
    Curr HIV Res; 2010 Mar; 8(2):141-6. PubMed ID: 20163350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.